Kindeva Drug Delivery
Quick Facts: Kindeva Drug Delivery
- Signal Score
- 76.1/100 (as of 2026-11-02)
- Quality Compliance
- 98.5/100 — Clean MHRA record: 9 compliant GMP certificates (no deductions)
- Headquarters
- Woodbury, MN
- Modalities
- Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Kindeva Drug Delivery
Pure-play CDMO.
Signal Score & Pillar Breakdown
Kindeva Drug Delivery FDA Inspection History
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2025-11-13 |
Kindeva Drug Delivery L.P.
Northridge, California
Facility-linked
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
| 2025-03-14 |
Kindeva Drug Delivery Limited
Loughborough
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2025-02-21 |
Summit Biosciences Inc.
Lexington, Kentucky
Company-level
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
Kindeva Drug Delivery FDA 483 Findings 4 observations · 2025-02-21 → 2025-11-13 ?
By subsystem
By severity
- 3 — Moderate: 1
- 2 — Minor: 3
- Repeat observations: 0
Most severe findings
-
No written record of investigation
"Written records are not always made of investigations into unexplained discrepancies."
-
Control procedures to monitor and validate performance
"Control procedures are not established which monitor the output and validate the performance of those manufacturing processes that may be responsible for causing variability in the characteristics of in-process material and the drug product."
-
Written in-process control procedures
"Written procedures are not established that describe the in-process controls and examinations to be conducted on appropriate samples of in-process materials of each batch."
Kindeva Drug Delivery MHRA GMP Compliance 9 certificates
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK MIA(IMP) 52811 Insp GMP/IMP 52811/17386-0042[I] | KINDEVA DRUG DELIVERY LIMITED | LOUGHBOROUGH LE11 5SF | 2025-03-11 | COMPLIANT |
| UK MIA 52811 Insp GMP/IMP 52811/17386-0042[H] | KINDEVA DRUG DELIVERY LIMITED | LOUGHBOROUGH LE11 5SF | 2025-03-11 | COMPLIANT |
| UK MIA(IMP) 52811 Insp IMP 52811/17386-0044[I] | KINDEVA DRUG DELIVERY LIMITED | LOUGHBOROUGH LE11 5SF | 2025-03-11 | COMPLIANT |
| UK MIA 45438 Insp GMP 45438/17386-0030[H] | KINDEVA DRUG DELIVERY LIMITED | LOUGHBOROUGH LE11 5SF | 2019-12-16 | COMPLIANT |
| UK GMP 48529 Insp GMP 48529/17389261-0001[H] | SUMMIT BIOSCIENCES INCORPORATED | 40511 | 2017-06-19 | COMPLIANT |
| UK GMP 48529 Insp GMP 48529/17451670-0001[H] | SUMMIT BIOSCIENCES INCORPORATED | 40511 | 2017-06-19 | COMPLIANT |
| UK GMP 10150 Insp GMP 10150/9135026-0001[H] | MERIDIAN MEDICAL TECHNOLOGIES INCORPORATED | 63144 | 2013-10-07 | COMPLIANT |
| UK GMP 10150 Insp GMP 10150/9135079-0001[H] | MERIDIAN MEDICAL TECHNOLOGIES INCORPORATED | 63146 | 2013-10-07 | COMPLIANT |
| UK GMP 8792 Insp GMP 8792/468212-0002[H] | 3M DRUG DELIVERY SYSTEMS | 91324 | 2012-07-26 | COMPLIANT |
Japan-accredited overseas site (PMDA)
general (non-sterile) · 1 site
- Loughborough, United Kingdom · Kindeva Drug Delivery Limited — general (non-sterile) · valid to Aug 17, 2030
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)